Based on these results, we concluded that during CRC development in mice, DCIR1 deficiency impairs the activation of CD4+ and CD8+ T cells in tumors, and the activation of CD8+ T cells in the mLNs. The gene discussed is CD4; the disease is colorectal carcinoma.